Abide Therapeutics, Inc. — Form D
Abide Therapeutics, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2011-11-18. The offering totals $2.3M, of which $2.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-11-18
- Form: D
- Accession: 0001535138-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.3M
- Amount sold: $2.2M
- Remaining: $50K
- Investors: 3
- Date of first sale: 2011-11-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-168913
Issuer
- Name: Abide Therapeutics, Inc.
- CIK: 0001535138
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 230 NASSAU STREET, PRINCETON, NJ, 08542
- Phone: 609-924-6452
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| John Clarke | Director | Geneva, V8 |
| Benjamine Cravatt | Director | Princeton, NJ |
| Alan Ezekowitz | Director | WATERTOWN, MA |
| Paul Schimmel | Director | Durham, NC |
| Alan Ezekowitz | Executive Officer | WATERTOWN, MA |
More